课题基金 / 基金详情

EFFECTS OF TESTOSTERONE REPLACEMENT ON MUSCLE PERFORMANCE & PHYSICAL FUNC IN MEN

EFFECTS OF TESTOSTERONE REPLACEMENT ON MUSCLE PERFORMANCE & PHYSICAL FUNC IN MEN
睾酮替代对肌肉性能的影响
批准号:
7379525
负责人:
SHALENDER BHASIN
金额:
$0.39万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

SHALENDER BHASIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. As men grow older, their muscles tend to become smaller and weaker. Muscle weakness makes it difficult for older people to move around to do activities of daily living and increases the risk of falls and injuries. Blood levels of the male hormone testosterone in men decrease with advancing age. Scientists believe that lower levels of testosterone may contribute to both th eloss of muscle strength, and performance in older men and that giving testosterone may help to improve muscle strength, physical activity, and overall sense of well-being. The primary purpose of this study is to find out whether testosterone replacement increases muscle strength, performance, and function in older men (age 65-85) with low muscle mass (sarcopenia) and low testosterone levels. Another objective is to find out whether th ereplacement of testosterone in these men improves the quality of life. It is a randomized placebo controlled trial of the effect of testosterone vs. placebo on these outcomes, in these men.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
  • 批准号:
    10430705
  • 项目类别:
  • 资助金额:
    $89.97万
  • 财政年份:
    2022
  • 负责人:
    SHALENDER BHASIN
  • 依托单位:
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
  • 批准号:
    10668324
  • 项目类别:
  • 资助金额:
    $86.81万
  • 财政年份:
    2022
  • 负责人:
    SHALENDER BHASIN
  • 依托单位:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
  • 批准号:
    10311161
  • 项目类别:
  • 资助金额:
    $75.21万
  • 财政年份:
    2021
  • 负责人:
    SHALENDER BHASIN
  • 依托单位:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
  • 批准号:
    10457489
  • 项目类别:
  • 资助金额:
    $87.31万
  • 财政年份:
    2021
  • 负责人:
    SHALENDER BHASIN
  • 依托单位:
海外基金